Adding a little on pullbacks, still looking to hold till it breaks 100 and then sone.
Recent DNLI News
- Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease • GlobeNewswire Inc. • 05/21/2026 10:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 02:06:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:12:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:03:26 PM
- Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights • GlobeNewswire Inc. • 05/07/2026 08:01:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:34:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:31:58 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/20/2026 11:22:10 PM
- When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech • InvestorsHub NewsWire • 04/20/2026 01:00:00 PM
- When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 06:43:37 PM
- Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN) • GlobeNewswire Inc. • 04/03/2026 05:30:00 PM
- The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step • PR Newswire (US) • 04/01/2026 12:49:00 AM
- The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step • PR Newswire (Canada) • 04/01/2026 12:49:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 12:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 07:13:02 PM
- Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II) • GlobeNewswire Inc. • 03/25/2026 03:50:28 PM
- Advanced Cell-based Therapy Booming the Success for Healthcare Sector • PR Newswire (Canada) • 03/24/2026 02:00:00 PM
- Advanced Cell-based Therapy Booming the Success for Healthcare Sector • PR Newswire (US) • 03/24/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 09:11:29 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2026 09:10:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:07:33 PM
- Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights • GlobeNewswire Inc. • 02/26/2026 09:01:00 PM
